| Literature DB >> 25348621 |
Tsuyoshi Fujita1, Benjamin J Burwitz2, Glen M Chew3, Jason S Reed2, Reesab Pathak2, Elizabeth Seger2, Kiera L Clayton4, James M Rini4, Mario A Ostrowski4, Naoto Ishii5, Marcelo J Kuroda6, Scott G Hansen2, Jonah B Sacha7, Lishomwa C Ndhlovu8.
Abstract
The T cell Ig- and mucin domain-containing molecule-3 (Tim-3) negative immune checkpoint receptor demarcates functionally exhausted CD8(+) T cells arising from chronic stimulation in viral infections like HIV. Tim-3 blockade leads to improved antiviral CD8(+) T cell responses in vitro and, therefore, represents a novel intervention strategy to restore T cell function in vivo and protect from disease progression. However, the Tim-3 pathway in the physiologically relevant rhesus macaque SIV model of AIDS remains uncharacterized. We report that Tim-3(+)CD8(+) T cell frequencies are significantly increased in lymph nodes, but not in peripheral blood, in SIV-infected animals. Tim-3(+)PD-1(+)CD8(+) T cells are similarly increased during SIV infection and positively correlate with SIV plasma viremia. Tim-3 expression was found primarily on effector memory CD8(+) T cells in all tissues examined. Tim-3(+)CD8(+) T cells have lower Ki-67 content and minimal cytokine responses to SIV compared with Tim-3(-)CD8(+) T cells. During acute-phase SIV replication, Tim-3 expression peaked on SIV-specific CD8(+) T cells by 2 wk postinfection and then rapidly diminished, irrespective of mutational escape of cognate Ag, suggesting non-TCR-driven mechanisms for Tim-3 expression. Thus, rhesus Tim-3 in SIV infection partially mimics human Tim-3 in HIV infection and may serve as a novel model for targeted studies focused on rejuvenating HIV-specific CD8(+) T cell responses.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25348621 PMCID: PMC4239185 DOI: 10.4049/jimmunol.1400961
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422